What is the value of multidisciplinary care for chronic kidney disease?
In a Persepctive, Richard Fluck and Maarten Taal discuss the potential value of implementing multidisciplinary care programs for chronic kidney disease.
Vyšlo v časopise:
What is the value of multidisciplinary care for chronic kidney disease?. PLoS Med 15(3): e32767. doi:10.1371/journal.pmed.1002533
Kategorie:
Perspective
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1002533
Souhrn
In a Persepctive, Richard Fluck and Maarten Taal discuss the potential value of implementing multidisciplinary care programs for chronic kidney disease.
Zdroje
1. Thomas B, Matsushita K, Abate KH, Al-Aly Z, Arnlov J, Asayama K, et al. Global Cardiovascular and Renal Outcomes of Reduced GFR. J Am Soc Nephrol. 2017;28(7): 2167–79. doi: 10.1681/ASN.2016050562 28408440
2. Chawla LS, Eggers PW, Star RA, Kimmel PL. Acute kidney injury and chronic kidney disease as interconnected syndromes. N Engl J Med. 2014;371(1): 58–66. doi: 10.1056/NEJMra1214243 24988558
3. Levin A, Tonelli M, Bonventre J, Coresh J, Donner JA, Fogo AB, et al. Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy. Lancet. 2017;390(10105): 1888–917. doi: 10.1016/S0140-6736(17)30788-2 28434650
4. Lin E, Chertow GM, Yan B, Malcolm E, Goldhaber-Fiebert JD. Cost-effectiveness of multi-disciplinary care in mild to moderate chronic kidney disease in the United States: A modeling study. PLoS Med. 2018;15(3): e1002532. doi: 10.1371/journal.pmed.1002532
5. Aiyegbusi OL, Kyte D, Cockwell P, Anderson N, Calvert M. A patient-centred approach to measuring quality in kidney care: patient-reported outcome measures and patient-reported experience measures. Curr Opin Nephrol Hypertens. 2017;26(6): 442–9. doi: 10.1097/MNH.0000000000000357 28806191
6. Tong A, Craig JC, Nagler EV, Van Biesen W. Composing a new song for trials: the Standardized Outcomes in Nephrology (SONG) initiative. Nephrol Dial Transplant. 2017;32(12): 1963–6. 29126280
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2018 Číslo 3
- Statiny indukovaná myopatie: Jak na diferenciální diagnostiku?
- MUDr. Dana Vondráčková: Hepatopatie sú pri liečbe metamizolom väčším strašiakom ako agranulocytóza
- Vztah mezi statiny a rizikem vzniku nádorových onemocnění − metaanalýza
- Nech brouka žít… Ať žije astma!
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
Najčítanejšie v tomto čísle
- Forced anal examinations to ascertain sexual orientation and sexual behavior: An abusive and medically unsound practice
- Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database
- The current and potential health benefits of the National Health Service Health Check cardiovascular disease prevention programme in England: A microsimulation study
- Cardiovascular disease and multimorbidity: A call for interdisciplinary research and personalized cardiovascular care